eEnzyme

eEnzyme is a specialized provider of research tools and contract services focused on virology and infectious diseases. Its core offerings include custom pseudovirus production for neutralization assays, a broad portfolio of recombinant viral proteins and antibodies, and engineered stable cell lines for drug discovery. The company serves academic, government, and biopharma researchers, positioning itself as a critical enabler for vaccine, therapeutic, and diagnostic development against high-priority pathogens. Its business model is based on product sales and fee-for-service work, generating revenue from the ongoing global need for infectious disease research capabilities.

Platforms for pseudovirus/VLP production, recombinant protein/antibody expression, and engineered stable cell lines for virology and membrane receptor research.

eEnzyme competes in the life science research tools market against large diversified corporations (e.g., Thermo Fisher Scientific, Merck Millipore) and specialized reagent companies (e.g., Sino Biological, Absolute Antibody). Its differentiation lies in its deep focus on virology, custom service agility, and expertise in pseudovirus production, carving out a niche among academic and biotech researchers needing specialized, high-quality tools for emerging pathogens.